Cancer Institute A national cancer institute
designated cancer center

Ann M. Arvin

Publication Details

  • Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for detection of serum antibodies to herpes simplex virus type 2 in patients with AIDS.

    Safrin S, Arvin A, Mills J, Ashley R. J Clin Microbiol. 1992; 30 (5): 1312-4

    Herpes simplex virus type 2 (HSV-2) seroprevalence in 68 patients with AIDS was 77% by Western blot (immunoblot) and 44% by glycoprotein G-2 immunoassay. Each of 16 patients with culture-proven HSV-2 infection was positive by Western blot versus 8 by glycoprotein G-2 immunoassay. No differences in age, race, duration of AIDS, acyclovir usage, or HSV-1 seroprevalence were found to explain differences in sensitivity.

    PubMedID: 1316370

Stanford Medicine Resources:

Footer Links: